- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05579990
Feasibility of Meal Delivery Postpartum
October 18, 2023 updated by: Camille S Worthington, PhD, University of Alabama at Birmingham
Feasibility of a Meal Delivery Intervention for Postpartum Weight Management
This study is being done to assess the feasibility and acceptability of a meal delivery intervention among low-income postpartum women with obesity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a single-group pilot study in which subjects will receive 10 home-delivered meals per week for 8 weeks.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Camille S Worthington, PhD
- Phone Number: 205-975-7274
- Email: cschneid@uab.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Camille Worthington, PhD
- Phone Number: 205-975-7274
- Email: cschneid@uab.edu
-
Principal Investigator:
- Camille S Worthington, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Medicaid eligible and/or have a household income at or below 185 percent of the federal poverty line
- 18 years of age or older
- Initiated prenatal care at a University of Alabama at Birmingham prenatal clinic
- Experienced a healthy singleton pregnancy
- 5-18 weeks postpartum at enrollment
- Body mass index >= 30 at enrollment
- Residing within the meal company's delivery radius
- Willing to consent
Exclusion Criteria:
- Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
- Current treatment for severe psychiatric disorder (such as schizophrenia)
- Self-reported diagnosis of anorexia or bulimia
- Current use of medication expected to significantly impact body weight
- Current substance abuse
- Participation in another dietary and/or weight management intervention postpartum
- Unable to understand and communicate in English
- Unwilling or unable to consume study meals
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Meal Delivery
Meal delivery intervention program designed to help low income postpartum women lose weight through weekly meal delivery and behavioral strategies.
|
10 home-delivered meals per week provided by a local meal delivery company supplemented by remote weekly behavioral support with study staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant Adherence to Intervention
Time Frame: Collected weekly from intervention start (6-21 weeks postpartum) to follow-up (14-29 weeks postpartum)
|
Proportion of weekly study meals participants consumed based on responses to weekly electronic surveys in which participants will report the number of study meals a) they consumed, b) other household members consumed, or c) that were uneaten.
|
Collected weekly from intervention start (6-21 weeks postpartum) to follow-up (14-29 weeks postpartum)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Study Participation Rate
Time Frame: baseline (5-19 weeks postpartum)
|
Percentage of eligible subjects who agreed to participate out of those who were screened
|
baseline (5-19 weeks postpartum)
|
Participant Retention
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
The proportion of enrolled participants who complete follow-up
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Change in Participant Satisfaction with Diet
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
To assess satisfaction with the study intervention, the 28-item Diet Satisfaction Questionnaire will be used in which participants respond to 28 statements using a 5-point Likert scale.
Responses are average to produce a total diet satisfaction score ranging from 1-5.
Changes in overall diet satisfaction, as well as changes in subscale scores for Cost Factor and Planning & Preparation Factor will be examined from baseline to follow-up.
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Weight
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Body weight measured at baseline and follow-up will be used to calculate weight change.
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Change in Food Security
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Determined using the 18-item United States (US) Household Food Security Survey Module based on the previous 30 days.
Adult food security scores range from 0 to 10, with lower values indicating greater food security.
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Change in Perceived Stress
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Determined using the 10-item Perceived Stress Scale (PSS-10) based on the last month.
PSS-10 scores range from 0 to 40, with higher scores representing higher levels of perceived stress.
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Change in Healthy Eating Self-Efficacy
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Participants will be asked to score 3 statements on a 5-point Likert scale ranging from 1=very sure to 5=very unsure (adapted from Lipsky LM et al. 2016).
Responses are reverse coded and averaged, so higher scores reflect increasing self-efficacy.
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Change in Weight Control Self-Efficacy
Time Frame: baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Participants will be asked to score 3 statements on a 5-point Likert scale ranging from 1=very sure to 5=very unsure (adapted from Lipsky LM et al. 2016).
Responses are reverse coded and averaged, so higher scores reflect increasing self-efficacy.
|
baseline (5-19 weeks postpartum), follow-up (14-29 weeks postpartum)
|
Change in Healthy Eating Index score from baseline to follow-up
Time Frame: three 24-hour dietary recalls on non-consecutive days at baseline (5-19 weeks postpartum) and follow-up (14-29 weeks postpartum)
|
Determined based on the Healthy Index Score, in which 100 indicates complete alignment with the Dietary Guidelines for Americans and 0 is the minimum score, as calculated from three 24-hour dietary recalls conducted on non-consecutive days (2 weekdays + 1 weekend day) at each time point.
|
three 24-hour dietary recalls on non-consecutive days at baseline (5-19 weeks postpartum) and follow-up (14-29 weeks postpartum)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Camille S Worthington, PhD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 27, 2023
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
October 11, 2022
First Submitted That Met QC Criteria
October 11, 2022
First Posted (Actual)
October 14, 2022
Study Record Updates
Last Update Posted (Actual)
October 23, 2023
Last Update Submitted That Met QC Criteria
October 18, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300010155
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual participant data (IPD) that underlie the results reported in a publication will be made available upon request beginning 9 months and ending 36 months following article publication.
The research team will keep a record of all individuals and/or research teams who request and receive a copy of the project data.
Interested investigators will be asked to submit a document indicating the specific aims of the analyses, the analytic plan, available resources for completing the proposed project, proposed timeline, and goals (i.e., manuscripts, presentations, and/or grant applications).
The PI and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed.
IPD Sharing Time Frame
Data requests can be submitted starting 9 months after publication of results and ending 36 months following article publication.
IPD Sharing Access Criteria
Access to IPD stripped of all HIPAA identifiers (except age) for this study can be requested by qualified researchers engaging in independent scientific research whose proposed research has received Institutional Review Board approval, and will be provided following review and approval of a research proposal and timeline, statistical analysis plan, and goals (e.g., manuscripts, presentations, grant applications).
The Principal Investigator (PI) and research team will review these requests to determine whether the proposed analyses constitute an innovative and significant exploration of the data, whether the proposed team has sufficient resources to complete the request, and whether data will be adequately protected and managed.
Based on institutional policies, execution of a Data Sharing Agreement may be required prior to sharing of IPD.
IPD requests can be made to the PI at cschneid@uab.edu.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Meal Delivery
-
Brown UniversityNational Institute on Aging (NIA); Meals on Wheels AmericaCompletedDementiaUnited States
-
University of Alabama at BirminghamRecruitingPregnancy Related | Weight Gain, MaternalUnited States
-
University of Alabama at BirminghamNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPregnancy | Diet, HealthyUnited States
-
Boston Children's HospitalCompletedObesity | Nutrition Disorders | Pediatric Obesity | Overnutrition, ChildUnited States
-
Kaiser PermanenteNational Institute on Minority Health and Health Disparities (NIMHD); Children...RecruitingOverweight and Obesity | Diet, HealthyUnited States
-
University at BuffaloNot yet recruitingFood Preferences | Food Habits
-
Johns Hopkins UniversityLeonard & Helen R. Stulman Charitable Foundation; Moveable Feast; Priority Partners... and other collaboratorsCompleted
-
Massachusetts General HospitalCompleted
-
McGill University Health Centre/Research Institute...RecruitingDiabetes Mellitus, Type 1 | Type 1 DiabetesCanada